Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 inter alia to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and year ended 31 March 2026 and to consider the declaration of dividend if any on the equity shares of the Company for the financial year 2025-26.